Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost.
Kim WJ, Roberts CC, Song JY, Yoon JG, Seong H, Hyun HJ, Lee H, Gil A, Oh Y, Park JE, Lee JE, Jeon B, Kane D, Spruill S, Kudchodkar SB, Muthumani K, Park YK, Kwon I, Maslow JN.
Kim WJ, et al. Among authors: roberts cc.
Vaccine. 2023 Jun 29;41(29):4206-4211. doi: 10.1016/j.vaccine.2023.06.013. Epub 2023 Jun 6.
Vaccine. 2023.
PMID: 37296017
Free PMC article.
Clinical Trial.